Variant report
Variant | esv3467220 |
---|---|
Chromosome Location | chr4:81508916-81510006 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs114892338 | chr4:81509021-81509022 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
2 | rs143740747 | chr4:81509054-81509055 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
3 | rs560551540 | chr4:81509072-81509073 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
4 | rs529907522 | chr4:81509096-81509097 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
5 | rs145759898 | chr4:81509104-81509105 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
6 | rs183233780 | chr4:81509107-81509108 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
7 | rs538435881 | chr4:81509118-81509119 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
8 | rs552397544 | chr4:81509146-81509147 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
9 | rs148936721 | chr4:81509166-81509167 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
10 | rs1385889 | chr4:81509175-81509176 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
11 | rs1385888 | chr4:81509178-81509179 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
12 | rs567056559 | chr4:81509210-81509211 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
13 | rs546598842 | chr4:81509219-81509220 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
14 | rs537561869 | chr4:81509229-81509230 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
15 | rs371365522 | chr4:81509304-81509305 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
16 | rs538755348 | chr4:81509316-81509317 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
17 | rs551958670 | chr4:81509334-81509335 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
18 | rs111602735 | chr4:81509352-81509353 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
19 | rs189240101 | chr4:81509359-81509360 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
20 | rs376281866 | chr4:81509373-81509374 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
21 | rs568838541 | chr4:81509401-81509402 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
22 | rs116001964 | chr4:81509449-81509450 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
23 | rs1872576 | chr4:81509452-81509453 | Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs565482181 | chr4:81509486-81509487 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
25 | rs574692079 | chr4:81509548-81509549 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
26 | rs373830184 | chr4:81509551-81509552 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
27 | rs113669937 | chr4:81509552-81509553 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Parkinson disease | 21956041 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 18414403 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Gastric cancer | 16891809 | CNVD |
Prostate cancer | 16573809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:81502200-81509000 | Weak transcription | Primary T helper naive cells fromperipheralblood | blood |
2 | chr4:81508000-81509000 | Enhancers | Fetal Kidney | kidney |
3 | chr4:81508400-81509600 | Bivalent Enhancer | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
4 | chr4:81508600-81509400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
5 | chr4:81508800-81509000 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
6 | chr4:81508800-81509000 | Enhancers | HMEC | breast |
7 | chr4:81508800-81509200 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
8 | chr4:81508800-81509200 | Enhancers | Primary hematopoietic stem cells | blood |
9 | chr4:81509000-81509200 | Enhancers | Primary T helper naive cells fromperipheralblood | blood |
10 | chr4:81509000-81509200 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |